Haem: Acute Leukaemia Flashcards

1
Q

Which cell level does CML tend to occur in?

A

Pluripotent haematopoietic stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which cell level does AML tend to occur in?

A

Pluripotent haematopoietic stem cell or multipotent myeloid stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some types of chromosomal abnormalities that are associated with AML.

A
  • Duplications
  • Loss
  • Translocation
  • Inversion
  • Deletion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can altered DNA sequence lead to leukaemia?

A
  • By the creation of a fusion gene
  • By abnormal regulation of genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which chromosomal duplications are most commonly associated with AML?

A

8 and 21 (there is a predisposition seen in Down syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some molecular abnormalities that an occur in apparently normal chromosomes.

A
  • Point mutations
  • Loss of function of tumour suppressor genes
  • Partial duplication
  • Cryptic deletion (formation of a fusion gene by deletion of a small section of DNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some risk factors for AML.

A
  • Familial
  • Constitutional (e.g. Down syndrome)
  • Anti-cancer drugs
  • Irradiation
  • Smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are type 1 and type 2 abnormalities with regards to leukaemogenesis?

A
  • Type 1: promote proliferation and survival (anti-apoptosis)
  • Type 2: block differentation

NOTE: leukaemogenesis in AML requires multiple genetic hits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main role of transcription factors?

A
  • They bind to DNA, alter the structure to favour transcription and, ultimately, regulate gene expression
  • Disruption of transcription factors can result in failure of differentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of how disruption of a transcription factor can lead to leukaemogenesis.

A
  • Core binding factor (CBF) is the master controller of haemopoiesis
  • Translocation 8;21 fuses RUNX1 leading to the formation of a fusion gene that drives leukaemia
  • The fusion transcription factor binds to co-repressors leading to a differentiation block
  • Inversion of chromosome 16 also affects CBF in a similar way
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which chromosomal aberration causes APML?

A

Translocation 15;17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a characteristic feature of APML? Why does this occur?

A
  • Haemorrhage - this is because APML is associated with DIC and hyperactive fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the fusion gene that is responsible for APML.

A

PML-RARA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In what way are the promyelocytes in APML considered ‘abnormal’?

A

They contain multiple Auer rods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how the variant version of APML is different from the original version.

A
  • The variant form has granules that are below the resolution of a light microscope
  • They also tend to have bilobed nuclei
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give a type 1 and type 2 mutation for APML.

A
  • Type 1: FLT3-ITD
  • Type 2: PML-RARA
17
Q

Give a type 1 and type 2 mutation for CBF leukaemias.

A
  • Type 1: sometimes mutated KIT
  • Type 2: mutations affecting function of CBF
18
Q

Which microscopic feature is pathognomonic of myeloid leukemias?

A

Auer rods

19
Q

Which stain can be used to distinguish myeloid leukaemias from other leukaemias?

A

Myeloperoxidase

20
Q

Name other similar stains that are not used as frequently for myeloid leukaemias (other than myeloperoxidase).

A
  • Sudan black
  • Non-specific esterase
21
Q

List the clinical features of AML.

A
  • Bone marrow failure (anaemia, neutropaenia, thrombocytopaenia)
  • Local infiltration (splenomegaly, hepatomegaly, gum infiltration, lymphadenopathy, CNS, skin)
  • Hyperviscosity if WBC is very high (can cause retinal haemorrhages and exudates)
22
Q

Outline the tests that may be used to diagnose AML.

A
  • Blood film
  • Bone marrow aspirate
  • Immunophenotyping
  • Cytogenetic studies (done in EVERY patient)
  • Molecular studies and FISH
23
Q

What is aleukaemia leukaemia?

A

When there are no leukaemic cells in the peripheral blood but the bone marrow has been replaced
i.e. can’t see anything on blood film, but bone marrow aspirate shows abnormalities

24
Q

Outline the supportive care given for AML.

A
  • Red cells
  • Platelets
  • FFC/cryoprecipitate in DIC
  • Antibiotics
  • Allopurinol (prevent gout)
  • Fluid and electrolyte balance
  • Chemotherapy
25
Q

What are the principles and outline of chemotherapy for AML?

A
  • Damage the DNA of leukaemic cells
  • Leave the normal cells unaffected
  • Combination chemotherapy is ALWAYS used
  • Usually given as 4-5 courses (2x remission induction + 2/3x consolidation)
  • Treatment usually lasts around 6 months
26
Q

List some determinants of prognosis in AML.

A
  • Patient characteristics
  • Morphology
  • Immunophenotyping
  • Cytogenetics
  • Response to treatment
27
Q

Outline the clinical features of ALL.

A

Bone marrow failure - neutropenia, thrombocytopenia, anaemia
Local infiltration
* Lymphadenopathy - +/- thymic enlargement (for T-lineage. B starts in the bone marrow)
* Splenomegaly
* Hepatomegaly
* Testes, CNS issues

28
Q

What is a key difference in the origin of B-lineage and T-lineage ALL?

A
  • B-lineage starts in the bone marrow
  • T-lineage can start in the thymus (which may be enlarged)
29
Q

List some possible leukaemogenic mechanisms in ALL.

A

Protooncogene dysregulation due to chromosomal abnormalities (resulting in fusion genes, altered gene promoters)

30
Q

List some investigations used in the diagnosis of ALL.

A
  • FBC and blood film
  • Bone marrow aspirate
  • Immunophenotyping
  • Cytogenetic/molecular analysis
31
Q

What are the four phases of chemotherapy for ALL?

A
  • Remission induction
  • Consolidation and CNS therapy
  • Intensification
  • Maintenance
32
Q

How long does chemotherapy for ALL usually take? Why is it longer in boys?

A

2-3 years

Longer in boys because the testes are a site of accumulation of lymphoblasts

33
Q

Who receives CNS-directed chemotherapy? How can this be given?

A
  • All patients should receive CNS-directed chemotherapy
  • This can be given intrathecally or a high dose of chemotherapy could be given such that it penetrates the BBB
34
Q

Outline the supportive care for ALL.

A
  • Blood products
  • Antibiotics
  • General medical care (central line, gout management, hyperkalaemia management, sometimes dialysis)